Status:
COMPLETED
Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young Children
Lead Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Conditions:
Hand, Foot and Mouth Disease
Anti-EV71
Eligibility:
All Genders
2-3 years
Brief Summary
Hand, Foot and Mouth Disease（HFMD）is an infectious disease in infants and young children caused by enterovirus. There was a great outbreak of HFMD in China, 2008, which brought not only panic to the p...
Detailed Description
Hand, Foot and Mouth Disease（HFMD）is a common infectious disease in infants and young children which is caused by enterovirus. HFMD is one of the category c infectious diseases in China. However a gro...
Eligibility Criteria
Inclusion
- The subjects participated in the clinical trial named 'The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health Neonates'in 2007 (ClinicalTrials.gov ID: NCT01183611).
- Written informed consent obtained from the parent(s) of the subject.
- Subjects who the investigator believes will comply with the requirements of the protocol.
Exclusion
- Neonatal jaundice requiring systemic treatment.
- Major congenital defects or serious chronic illness.
- Maldevelopment
- Any condition that in the opinion of the investigator, may interfere with the evaluation of study objectives
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2011
Estimated Enrollment :
1297 Patients enrolled
Trial Details
Trial ID
NCT01255124
Start Date
October 1 2010
End Date
September 1 2011
Last Update
September 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jiangsu Provincial Center for Diseases Control and Prevention
Nanjing, Jiangsu, China, 210009